These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3267058)

  • 1. Interleukin-2 induced changes in mononuclear cell surface charge.
    Jenkins R; Williams AC; Limb GA; Brown KA; Dumonde DC
    Adv Exp Med Biol; 1988; 237():433-8. PubMed ID: 3267058
    [No Abstract]   [Full Text] [Related]  

  • 2. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
    Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB
    J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison between interleukin-2- and mannoprotein-activated MHC-unrestricted, killer cells in human peripheral blood mononuclear cells.
    Palma C; Ausiello C; Spagnoli GC; Casalinuovo I; Cassone A; Casciani CU
    J Chemother; 1989 Jul; 1(4 Suppl):449-51. PubMed ID: 16312480
    [No Abstract]   [Full Text] [Related]  

  • 4. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil.
    Brazowski E; Eytan K; Eisenthal A
    Anticancer Res; 2007; 27(6B):4135-41. PubMed ID: 18225584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human NK resistant tumor cell lysis is effected by IL-2 activated killer cells.
    Grimm EA; Rayner AA; Wilson DJ
    Adv Exp Med Biol; 1985; 184():161-75. PubMed ID: 2994409
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro activation of NK cytotoxicity with IL-2.
    Ibayashi Y; Tokuda Y; Saks ER; Sarna GP; Golub SH
    Prog Clin Biol Res; 1987; 244():275-85. PubMed ID: 3498954
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of NK Cells in Mixed Cultures of Wharton's Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes.
    Svirshchevskaya EV; Poltavtsev AM; Os'mak GZ; Poltavtseva RA
    Bull Exp Biol Med; 2018 Jan; 164(3):339-343. PubMed ID: 29313232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heat-pretreatment on interleukin-2-activated killer cells for in vitro purging.
    Tanaka M; Honda J; Imamura Y; Shiraishi K; Tanaka K; Oizumi K
    Pathobiology; 2000; 68(3):124-8. PubMed ID: 11174069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
    Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated killer cell activity of spleen cells from patients with gastric carcinoma.
    Akiyoshi T; Koba F; Arinaga S; Tsuji H
    J Clin Lab Immunol; 1987 Aug; 23(4):197-201. PubMed ID: 2959788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signals for activation of natural killer and natural killer-like activity.
    Shau HY; Golub SH
    Nat Immun Cell Growth Regul; 1985; 4(3):113-9. PubMed ID: 2413352
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial cell lysis induced by lymphokine-activated human peripheral blood mononuclear cells.
    Miltenburg AM; Meijer-Paape ME; Daha MR; Paul LC
    Eur J Immunol; 1987 Sep; 17(9):1383-6. PubMed ID: 3308489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic factor produced from lymphokine-activated killer (LAK) cells.
    Mizoguchi Y; Sakagami Y; Seki S; Kobayashi K; Yamamoto S; Morisawa S
    Osaka City Med J; 1988 Oct; 34(2):223-35. PubMed ID: 3266320
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
    Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
    Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of interleukin 10 on interleukin 12- and interleukin 2-mediated killer induction from blood mononuclear cells.
    Pai K; Yanagawa H; Takauchi E; Suzuki Y; Hanibuchi M; Parajuli P; Sone S
    Oncol Res; 1998; 10(6):295-300. PubMed ID: 9848100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection.
    Hsia J; Goldstein AL; Simon GL; Sztein M; Hayden FG
    J Infect Dis; 1990 Sep; 162(3):591-7. PubMed ID: 2167330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.